ATE269897T1 - Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion - Google Patents
Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektionInfo
- Publication number
- ATE269897T1 ATE269897T1 AT99106453T AT99106453T ATE269897T1 AT E269897 T1 ATE269897 T1 AT E269897T1 AT 99106453 T AT99106453 T AT 99106453T AT 99106453 T AT99106453 T AT 99106453T AT E269897 T1 ATE269897 T1 AT E269897T1
- Authority
- AT
- Austria
- Prior art keywords
- validation
- methods
- intrameric
- identifying
- vivo selection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99106453A EP1041144B1 (de) | 1999-03-29 | 1999-03-29 | Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE269897T1 true ATE269897T1 (de) | 2004-07-15 |
Family
ID=8237883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99106453T ATE269897T1 (de) | 1999-03-29 | 1999-03-29 | Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070287153A1 (de) |
EP (2) | EP1041144B1 (de) |
JP (1) | JP2002539825A (de) |
AT (1) | ATE269897T1 (de) |
AU (1) | AU3558000A (de) |
CA (1) | CA2365297A1 (de) |
DE (1) | DE69918260T2 (de) |
WO (1) | WO2000058455A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1223216A1 (de) * | 2000-12-30 | 2002-07-17 | NascaCell GmbH | Intrazelluläre Nukleinsäureinhibitoren kleiner Guaninnukleotid-Austauschfaktoren |
WO2011125852A1 (ja) * | 2010-04-01 | 2011-10-13 | Necソフト株式会社 | 核酸構築物、それを用いた複合体の製造方法およびスクリーニング方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5707796A (en) * | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
WO1996038553A1 (en) * | 1995-06-02 | 1996-12-05 | M&E Biotech A/S | A method for identification of biologically active peptides and nucleic acids |
US6187757B1 (en) * | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
CA2244222A1 (en) * | 1996-01-23 | 1997-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and rna molecules |
WO1997039722A2 (en) * | 1996-04-25 | 1997-10-30 | T Cell Sciences, Inc. | Method of isolating regulators of t cell activation |
AU5927598A (en) * | 1997-01-23 | 1998-08-18 | Immusol Incorporated | Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
-
1999
- 1999-03-29 AT AT99106453T patent/ATE269897T1/de not_active IP Right Cessation
- 1999-03-29 EP EP99106453A patent/EP1041144B1/de not_active Expired - Lifetime
- 1999-03-29 DE DE69918260T patent/DE69918260T2/de not_active Expired - Fee Related
-
2000
- 2000-03-28 WO PCT/EP2000/002727 patent/WO2000058455A2/en active Application Filing
- 2000-03-28 JP JP2000608736A patent/JP2002539825A/ja active Pending
- 2000-03-28 AU AU35580/00A patent/AU3558000A/en not_active Abandoned
- 2000-03-28 EP EP00914168A patent/EP1165770A2/de not_active Withdrawn
- 2000-03-28 CA CA002365297A patent/CA2365297A1/en not_active Abandoned
-
2006
- 2006-05-25 US US11/440,907 patent/US20070287153A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2365297A1 (en) | 2000-10-05 |
JP2002539825A (ja) | 2002-11-26 |
US20070287153A1 (en) | 2007-12-13 |
WO2000058455A3 (en) | 2001-01-04 |
DE69918260D1 (de) | 2004-07-29 |
DE69918260T2 (de) | 2005-07-14 |
EP1041144B1 (de) | 2004-06-23 |
EP1041144A1 (de) | 2000-10-04 |
WO2000058455A2 (en) | 2000-10-05 |
EP1165770A2 (de) | 2002-01-02 |
AU3558000A (en) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE309536T1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
ATE302267T1 (de) | Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert | |
ATE364696T1 (de) | Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts | |
DE60323067D1 (de) | Verfahren zur erzeugung doppelsträngiger dna mit einem 3'-einzelstranganteil und verwendungen dieser komplexe zur rekombination | |
DE69534629D1 (de) | Derivate von zinkfingerproteinen und methoden | |
HK1027820A1 (en) | Molecules that home to a selected organ or tissue in vivo | |
DE69926797D1 (de) | Sequenzierungsverfahren mit signalverstärkern | |
DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
DE69942451D1 (de) | Methode zum schnellen identifizieren von kleinen organischen liganden | |
DE60323231D1 (de) | Verkürzte tau proteine | |
EA200600561A1 (ru) | Фармацевтический препарат для лечения шока | |
ATE417930T1 (de) | Proteinkinase npk-110 | |
ATE534902T1 (de) | Replikationsproteinn ciz1 | |
ATE445023T1 (de) | Auf nukleinsäurenamplifizierung basierendes verfahren zur bestimmung von methylierungsprofil und reagenzien dafür | |
ATE269897T1 (de) | Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion | |
WO2004033485A3 (en) | Nucleic acid supported protein complementation | |
HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
DE60107888D1 (de) | Beta-Interferon zur Behandlung von Immunerkrankungen | |
ATE214708T1 (de) | Kationische mittel zur transfektion von nukleinsäuren | |
WO2003016343A3 (en) | USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS | |
WO2007019421A3 (en) | Regulation of of s6 kinase protein activity and related methods | |
WO2003012103A3 (fr) | Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie | |
WO2003012102A3 (fr) | Acides nucleiques codant des proteines a domaine hect | |
WO2003040320A3 (en) | Antisense modulation of human collapsin response mediator protein 2 expression | |
HUP0002766A2 (hu) | Eljárás p53-fehérje célgénhez történő kapcsolódásának befolyásolására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |